Search Results for "brca1"

https://myriad.com/genetic-tests/myrisk-hereditary-cancer-risk-test/

MyRisk ® Hereditary Cancer Test with RiskScore - Myriad Genetics

The MyRisk Test offers the industry's lowest reported VUS rates for BRCA1 and BRCA2 of 0.3% and 0.7%, respectively.⁷. Lifetime Classification Commitment.

https://investor.myriad.com/news-releases/news-release-detail/11596/

Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials

Jun 19, 2007 ... ... BRCA1 or BRCA2. The BRCA1 and BRCA2 genes are involved in DNA repair and when this function is lost due to a mutation, cells are unable to ...

https://investor.myriad.com/news-releases/news-release-detail/11381/

Myriad Applauds New ACOG Guidelines for Hereditary Breast and ...

Mar 24, 2009 ... Germline mutations in BRCA1 and BRCA2 account for the vast majority of families with hereditary breast and ovarian cancer syndrome. BRCA1 and ...

https://investor.myriad.com/news-releases/news-release-detail/10721/

Myriad Introduces Enhanced BRACAnalysis® Test for Exceptionally ...

Aug 1, 2006 ... The added test detects rare, large rearrangements of the DNA in the BRCA1 and BRCA2 genes and will be performed for women with exceptionally high risk.

https://investor.myriad.com/news-releases/news-release-detail/11401/

New Study Published in CANCER Supports Use of BRACAnalysis ...

Apr 30, 2009 ... (NASDAQ: MYGN) announced today that an article entitled "BRCA1 and BRCA2 Mutations in Women of Different Ethnicities Undergoing Testing for ...

https://investor.myriad.com/news-releases/news-release-detail/24686/

Myriad Genetics Applauds New Germline Testing Guideline for ...

Jan 9, 2024 ... ... BRCA1/2 testing. All patients with a current or previous diagnosis of invasive breast cancer > 65 years should be offered BRCA1/2 testing if ...

https://investor.myriad.com/news-releases/news-release-detail/10936/

Myriad and TESARO Enter Into Companion Diagnostic Agreement

Jun 24, 2013 ... BRACAnalysis is a genetic test that confirms the presence of a BRCA1 or BRCA2 gene mutation. BRCA mutations are responsible for the majority ...

https://investor.myriad.com/news-releases/news-release-detail/12041/

Myriad myRisk® Hereditary Cancer Article in Journal of Clinical ...

Mar 30, 2016 ... "This is the first study to show the frequency of germline mutations in BRCA1/2 and other breast cancer predisposition genes in a sequential ...

https://investor.myriad.com/news-releases/news-release-detail/11621/

Myriad myRisk Hereditary Cancer™ Test Significantly Improves ...

Dec 12, 2013 ... ... BRCA1 and BRCA2 genes alone. myRisk is a new diagnostic test that uses next-generation sequencing technology to evaluate 25 genes associated ...

https://investor.myriad.com/news-releases/news-release-detail/11646/

Myriad Publishes myRisk Hereditary Cancer Study in Cancer

Sep 3, 2014 ... ... BRCA1/2 testing, and 377 patients with a personal and family history who previously tested negative for BRCA mutations. Deleterious ...